According to global research data released by the World Health Organization (Bray et al., 2018), there were approximately 2.1 million newly diagnosed breast cancer (BCa) patients in 2018.In China, BCa accounts for 15% of all new female cancer cases and is still the most frequently diagnosed cancer in women (Chen et al., 2016). In addition to the high incidence rate of BCa, the survival rate is also increasing. In a survey conducted in 72 regions in China, the 5-year survival rate of BCa patients reached 58%-90% (Li et al., 2016), which is due in part to the availability of multiple effective treatments. Surgery is the most basic and common treatment for early BCa.A study of 3,846 Chinese BCa patients showed that 88.27% underwent surgery (Situ et al., 2015). In addition, the choice of surgery has evolved from single mastectomy to a number of options, including lumpectomy and reconstruction after mastectomy. It is generally verified that the survival rate for lumpectomy plus radiation is the same as that for mastectomy (Fisher et al., 2002). However, the fear of recurrence may be high among women who prefer to undergo